Michael Harold Rock

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: H. Lundbeck A/s, Cephalon, Inc.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Harold Rock. Retrieved from https://idiyas.com/inventor/michael-harold-rock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 55.0

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 51(Granted Patents)

Location History:

Fredirksberg C, DK (2013)
Hvidovre, DK (2002 - 2015)
Frederiksberg C, DK (2014 - 2018)

Company Filing History:

Years Active: 2002-2018

Loading Chart...

Areas of Expertise:

Alzheimer's Disease

Pharmaceutical Agent

Crystalline Compounds

Citalopram

S-Citalopram

Piperazine

Purification

Manufacturing Processes

Orodispersible Tablets

Dimethylphenylsulfanyl

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10071963 - Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease (2018-09-11),

2. 9382205 - Processes for the manufacture of a pharmaceutically active agent (2016-07-05),

3. 9101626 - Process for preparing 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or pharmaceutically acceptable salt thereof (2015-08-11),

4. 9095588 - Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereof (2015-08-04),

5. 8901318 - Processes for the manufacture of a pharmaceutically active agent (2014-12-02),

6. 8729065 - Crystalline forms of a pharmaceutical compound (2014-05-20),

7. 8598348 - Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (2013-12-03),

8. 8461353 - Processes for the manufacture of a pharmaceutically active agent (2013-06-11),

9. 8362255 - Process for the manufacture of [phenylsulfanylphenyl]piperidines (2013-01-29),

10. 8076320 - Crystalline forms of a pharmaceutical compound (2011-12-13),

11. 7834201 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2010-11-16),

12. 7723533 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2010-05-25),

13. 7560576 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2009-07-14),

14. 7271273 - Method for the preparation of citalopram (2007-09-18),

15. 7112686 - Process for the preparation of racemic citalopram and/or S-or R-citalopram by separation of a mixture of R-and S-citalopram (2006-09-26),

Title: Michael Harold Rock - Innovative Inventor from Hvidovre

Introduction: Michael Harold Rock is a renowned inventor hailing from Hvidovre, Denmark, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Michael Harold Rock's latest patents include advancements in renewable energy technologies, sustainable materials, and smart home devices, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Michael Harold Rock has established himself as a pioneer in the innovation industry, with numerous successful inventions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Michael Harold Rock has collaborated with leading research institutions, universities, and companies worldwide to bring his inventions to life, fostering a culture of innovation and creativity in the process.

Conclusion: Michael Harold Rock's passion for innovation and dedication to creating a better future through his inventions make him a standout figure in the world of inventors, inspiring generations to come.

Profile summary based on public USPTO records.